To help those who suffer from and are at risk of Neglected Tropical Diseases in sub-Saharan Africa.
SCI works with governments in sub-Saharan Africa to create or scale up programs that treat schistosomiasis and soil-transmitted helminthiasis (STH) ("deworming"). SCI's role has primarily been to identify country recipients, provide funding to governments for government-implemented programs, provide advisory support, and conduct monitoring and evaluation on the process and outcomes of the programs. GiveWell believes that there is relatively strong evidence for the positive impact of deworming.
Where they work:
Senegal | Liberia | Cote d'lvoire | Nigeria | Niger | Sudan | Ethiopia | Uganda | Rwanda | Burundi | Democratic Republic of Congo | Tanzania | Zanzibar | Zambia | Malawi | Mozambique | Madagascar | Mauritania
What they do
SCI treats children and at risk adults for schistosomiasis and soil transmitted helminths (STH - whipworm, hookworm, roundworm), preventing anaemia, impaired growth and development in children and the development of life-threatening conditions of bladder cancer, kidney malfunction or liver and spleen damage.
They assist Ministries of Health across sub-Saharan Africa to control and then eliminate schistosomiasis and STH from their population utilising the World Health Organization’s Drug Donation Programme for praziquantel and albendazole.
230 million people, one-third of the total population of Africa, need a regular annual treatment of praziquantel, and 400 million people need a regular annual treatment of albendazole, to eliminate these parasitic diseases from their bodies.
- Treat children & at risk adults for schistosomiasis & STHs (i.e. whipworm, hookworm, roundworm) (NTDs) caused by parasitic worms.
- Logistical support:
- mapping the prevalence of the disease,
- formulation of a strategy plan,
- requesting and obtaining praziquantel from the donation programme managed by WHO,
- training staff for implementation, monitoring and evaluation of the programme.